Pdt Partners, LLC Amneal Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $242,902 - $403,956	88,008 New	88,008 $371,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $124,595 - $223,285	-61,681 Reduced 47.4%	68,449 $138,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $20,124 - $29,819	-6,686 Reduced 4.89%	130,130 $414,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $102,375 - $128,362	26,250 Added 23.74%	136,816 $571,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $436,735 - $646,811	110,566 New	110,566 $530,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $155,246 - $203,152	-36,020 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $184,422 - $245,656	36,020 New	36,020 $184,000

189

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.31B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.